{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:31:06Z","timestamp":1790829066740,"version":"4.1.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Cardiogenic shock (CS) is a severe syndrome with poor prognosis. Short-term mechanical circulatory support with Impella devices has emerged as an increasingly therapeutic option, unloading the failing left ventricle (LV) and improving hemodynamic status of affected patients. Impella devices should be used for the shortest time necessary to allow LV recovery because of time-dependent device-related adverse events. The weaning from Impella, however, is mostly performed in the absence of established guidelines, mainly based on the experience of the individual centres.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The aim of this single center study was to retrospectively evaluate whether a multiparametrical assessment before and during Impella weaning could predict successful weaning. The primary study outcome was death occurring during Impella weaning and secondary endpoints included assessment of in-hospital outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of a total of 45 patients (median age, 60 [51\u201366] years, 73% male) treated with an Impella device, 37 patients underwent impella weaning\/removal and 9 patients (20%) died after the weaning. Non-survivors patients after impella weaning more commonly had a previous history of known heart failure (<jats:italic>p<\/jats:italic>\u2009=\u20090.054) and an implanted ICD-CRT (<jats:italic>p<\/jats:italic>\u2009=\u20090.01), and were more frequently treated with continuous renal replacement therapy (<jats:italic>p<\/jats:italic>\u2009=\u20090.02). In univariable logistic regression analysis, lactates variation (%) during the first 12\u201324\u2005h of weaning, lactate value after 24\u2005h of weaning, left ventricular ejection fraction (LVEF) at the beginning of weaning, and inotropic score after 24\u2005h from weaning beginning were associated with death. Stepwise multivariable logistic regression identified LVEF at the beginning of weaning and lactates variation (%) in the first 12\u201324\u2005h from weaning beginning as the most accurate predictors of death after weaning. The ROC analysis indicated 80% accuracy (95% confidence interval\u2009=\u200964%\u201396%) using the two variables in combination to predict death after weaning from Impella.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This single-center experience on Impella weaning in CS showed that two easily accessible parameters as LVEF at the beginning of weaning and lactates variation (%) in the first 12\u201324\u2005h from weaning begin were the most accurate predictors of death after weaning.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2023.1171956","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T09:54:23Z","timestamp":1687341263000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Clinical outcomes and predictors of success with Impella weaning in cardiogenic shock: a single-center experience"],"prefix":"10.3389","volume":"10","author":[{"given":"M. V.","family":"Matassini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Marini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Angelozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Angelini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Shkoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Compagnucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Falanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Battistoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pongetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Francioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Piva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mucaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Nicolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Maolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Di Eusanio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Munch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dello Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Perna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/JAHA.119.011991","article-title":"Cardiogenic shock","volume":"8","author":"Vahdatpour","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary management of cardiogenic shock: a scientific statement from the American heart association","volume":"136","author":"Van Diepen","year":"2017","journal-title":"Circ"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-015-1073-8","article-title":"Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock","volume":"19","author":"Gaudard","year":"2015","journal-title":"Crit Care"},{"key":"B6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/2048872617743194","article-title":"Single-centre experience with the Impella CP, 5.0 and RP in 109 consecutive patients with profound cardiogenic shock","volume":"7","author":"Jensen","year":"2018","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"B7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1161\/CIRCHEARTFAILURE.112.967224","article-title":"Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock results of the Impella-EUROSHOCK-registry","volume":"6","author":"Lauten","year":"2013","journal-title":"Circ Heart Fail"},{"key":"B8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/2048872616633877","article-title":"Short-term mechanical circulatory support with the Impella 5.0 device for cardiogenic shock at la piti\u00e9-salp\u00eatri\u00e8re","volume":"6","author":"Mastroianni","year":"2017","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"B9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.21037\/acs.2018.12.01","article-title":"Temporary mechanical circulatory support for refractory heart failure: the German heart center Berlin experience","volume":"8","author":"Nersesian","year":"2019","journal-title":"Ann Cardiothorac Surg"},{"key":"B10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1177\/2048872618805486","article-title":"Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experience","volume":"8","author":"Ouweneel","year":"2019","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"B11","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jacc.2016.10.026","article-title":"Percutaneous mechanical circulatory support versus intra-aortic balloon pump for treating cardiogenic shock: meta-analysis","volume":"69","author":"Ouweneel","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1016\/j.jacc.2008.05.065","article-title":"A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction","volume":"52","author":"Seyfarth","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"A23","DOI":"10.1093\/eurheartj\/suab004","article-title":"Pump flow setting and assessment of unloading in clinical practice","volume":"23","author":"M\u00f8ller","year":"2021","journal-title":"Eur Heart J Suppl"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2020.12.054","article-title":"Managing patients with short-term mechanical circulatory support","volume":"77","author":"Balthazar","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1111\/aor.14197","article-title":"Hemodynamic assessment and risk classification for successful weaning of Impella in patients with cardiogenic shock","volume":"46","author":"Ikeda","year":"2022","journal-title":"Artif Organs"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcvm.2021.563484","article-title":"The \u201cTIDE\u201d-algorithm for the weaning of patients with cardiogenic shock and temporarily mechanical left ventricular support with Impella devices. A cardiovascular physiology-based approach","volume":"8","author":"Tsch\u00f6pe","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"A41","DOI":"10.1093\/eurheartj\/suab008","article-title":"Weaning from Impella and mobilization of Impella patients","volume":"23","author":"Bertoldi","year":"2021","journal-title":"Eur Heart J Suppl"},{"key":"B18","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.jchf.2021.05.011","article-title":"A pragmatic approach to weaning temporary mechanical circulatory support: a state-of-the-art review","volume":"9","author":"Randhawa","year":"2021","journal-title":"JACC Hear Fail"},{"key":"B19","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ijcard.2015.07.065","article-title":"Impella ventricular support in clinical practice: collaborative viewpoint from a European expert user group","volume":"201","author":"Burzotta","year":"2015","journal-title":"Int J Cardiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"B22","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1097\/MAT.0b013e3182a4b32e","article-title":"Levosimendan may improve weaning outcomesin venoarterial ECMO patients","volume":"59","author":"Affronti","year":"2013","journal-title":"ASAIO J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/aor.13899","article-title":"Levosimendan in veno-arterial extracorporeal membrane oxygenator supported patients: impact on the success of weaning and survival","volume":"45","author":"Alonso-Fernandez-Gatta","year":"2021","journal-title":"Artif Organs"},{"key":"B24","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1053\/j.jvca.2018.08.102","article-title":"Early versus late treatment with levosimendan during temporary mechanical circulatory support","volume":"32","author":"Gaudard","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"B25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ijcard.2016.06.023","article-title":"Retrospective analysis of circulatory support with the Impella CP\u00ae device in patients with therapy refractory cardiogenic shock","volume":"219","author":"Lackermair","year":"2016","journal-title":"Int J Cardiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"101007","DOI":"10.1016\/j.ijcha.2022.101007","article-title":"Use of Impella device in cardiogenic shock and its clinical outcomes: asystematic review and meta-analysis","volume":"40","author":"Panuccio","year":"2022","journal-title":"IJC Heart Vasc"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1171956\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T09:54:25Z","timestamp":1687341265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1171956\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,21]]},"references-count":26,"alternative-id":["10.3389\/fcvm.2023.1171956"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1171956","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,21]]},"article-number":"1171956"}}